Ridwanullah Abiodun Abubakar

Ridwanullah Abiodun Abubakar

Auto-generated profile, based on publicly available information

Ridwanullah Abiodun Abubakar

Division of Molecular and Integrative Physiology, Southern Illinois University School of Medicine , Carbondale, IL 62901-6523

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2025 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
PDPratyusa Das
Pratyusa Das
CSCaitlin E. Stallings
Caitlin E. Stallings
RARidwanullah A. Abubakar
Ridwanullah A. Abubakar
NMNooshin Mojahed
Nooshin Mojahed
SGShalini Guha
Shalini Guha
BEBuffy S. Ellsworth
Buffy S. Ellsworth

21 January 2026 in Oxford Open Immunology
Verified
Journal Article
Open access
SASheu Ibrahim Adedayo
Sheu Ibrahim Adedayo
TGTaiye Abdullahi Gegele
Taiye Abdullahi Gegele
KAKehinde Ahmad Adeshina
Kehinde Ahmad Adeshina
BOBaliqis Olukade
Baliqis Olukade
RARidwanullah Abiodun Abubakar
Ridwanullah Abiodun Abubakar
Kasimu IbrahimKasimu Ibrahim
Kasimu Ibrahim
TAM receptors, composed of Tyro3, Axl, and Mertk, belong to the receptor tyrosine kinase family and are activated by binding of their cognate ligands, Gas6 and Pros1. These receptor-ligand interactions mediate critical physiological processes, including the maintenance of immunological equilibrium, thrombocyte aggregation and subsequent thrombus development, apoptotic cellular debris clearance, homeostatic regulation of endothelial and vascular smooth muscle cells, and erythrocyte production. Perturbations in TAM signaling cascades have been shown to compromise the clearance of apoptotic cells, leading to persistent inflammatory responses that can contribute to the development of various autoimmune pathologies, including multiple sclerosis, rheumatoid arthritis, Sjögren’s syndrome, and systemic lupus erythematosus. We retrieved and reviewed only the primary studies addressing the roles of TAM receptors and their ligands in selected autoimmune diseases from Google Scholar, Scopus, Web of Science, and PubMed. The critical roles of TAM receptors in immune homeostasis and apoptotic cell clearance are well established. However, findings from several primary studies discussed in this review further emphasized that the loss of TAM receptor function in these processes significantly contributes to the pathogenesis and progression of autoimmune diseases. Herein, we highlight the role of TAM receptors in several autoimmune diseases, suggesting that TAM receptors are potential biomarkers for monitoring disease prognosis and therapeutic targets to improve patient outcomes.

16 May 2026 in Endocrinology
Verified
Journal Article
Open access
PDPratyusa Das
Pratyusa Das
RARidwanullah A Abubakar
Ridwanullah A Abubakar
NMNooshin Mojahed
Nooshin Mojahed
DADania Abou-Jabal
Dania Abou-Jabal
PKPrisha Kittu
Prisha Kittu
BEBuffy S Ellsworth
Buffy S Ellsworth
Glucocorticoids are an important signal for the differentiation of many types of cells. Consistent with this, several studies have demonstrated that glucocorticoids promote the somatotrope differentiation program and functionality. Interestingly, we previously found that loss of the forkhead factor, FOXO1, results in delayed emergence of somatotropes and prevents glucocorticoid-induced premature differentiation of somatotropes. In the present study, we find that pituitary-specific deletion of Nr3c1, the gene encoding the glucocorticoid receptor, impairs somatotrope differentiation and increases lactotrope numbers embryonically and at 5 days after birth. The number of somatotropes remains reduced at age 7 weeks in females and males, but lactotrope cell numbers are increased only in females at this age. FOXO1 is nearly undetectable in pituitary glands from mouse embryos lacking NR3C1 and continues to be reduced in adults. These findings suggest that glucocorticoids are an important signal for determining the balance between somatotropes and lactotropes and that FOXO1 may mediate NR3C1 induction of somatotrope differentiation.

9 September 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
CMCaroline Vilas Boas de Melo
Caroline Vilas Boas de Melo
MBMaruf Ahmed Bhuiyan
Maruf Ahmed Bhuiyan
WGWinfred Nyoroka Gatua
Winfred Nyoroka Gatua
SKStephen Kanyerezi
Stephen Kanyerezi
Leonard Ighodalo UzairueLeonard Ighodalo Uzairue
Leonard Ighodalo Uzairue
SCSarah H. Carl
Sarah H. Carl
Introduction: Over 24 million people have been infected globally with the novel coronavirus, SARS-CoV-2, with more than 820,000 succumbing to the resulting COVID-19 disease as of the end of August 2020. The molecular mechanisms underlying the pathogenesis of the disease are not completely elucidated. Thus, we aim to understand host response to SARS-CoV-2 infection by comparing samples collected from two distinct compartments (infection site and blood), obtained from COVID-19 subjects and healthy controls. Methods: We used two publicly available gene expression datasets generated via RNA sequencing in two different samples; nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs). We performed a differential gene expression analysis between COVID-19 subjects and healthy controls in the two datasets and then functionally profiled their differentially expressed genes (DEGs). The genes involved in innate immunity were also determined. Results: We found a clear difference in the host response to SARS-CoV-2 infection between the two sample groups. In COVID-19 subjects, the nasopharyngeal sample group indicated upregulation of genes involved in cytokine activity and interferon signalling pathway, as well as downregulation of genes involved in oxidative phosphorylation and viral transcription. Host response in COVID-19 subjects for the PBMC group, involved upregulation of genes involved in the complement system and immunoglobulin mediated immune response. CXCL13, GABRE, IFITM3 were upregulated and HSPA1B was downregulated in COVID-19 subjects in both sample groups. Conclusion: Our results indicate the host response to SARS-CoV-2 is compartmentalized and suggests potential biomarkers of response to SARS-CoV-2 infection. Highlights: Transcriptomic profiling from publicly available RNA-seq count data revealed a site-specific immune response in COVID-19. Host response was found cellular-mediated in nasopharyngeal samples and humoral-mediated in PBMCs samples. CXCL13, GABRE and IFITM3 commonly upregulated and HSPA1B downregulated in both sample groups highlights the potential of these molecules as markers of response to SARS-CoV-2 infection.